Recruiting
GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell Malignancies
NCT06948981
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancy (Leukemia- Lymphoma), +3 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China